An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
Top results in this bookTable of Contents
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
MotherToBaby | Fact Sheets [Internet].
Brentwood (TN): Organization of Teratology Information Specialists (OTIS); 1994-.
Mogamulizumab (Poteligeo): CADTH Reimbursement Review: Therapeutic area: Mycosis fungoides, Sézary syndrome [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo): Therapeutic area: Acne vulgaris: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Feb.
Clascoterone (Winlevi): Therapeutic area: Acne vulgaris: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Jun.
Management options for mild to moderate acne – network meta-analyses: Acne vulgaris: management: Evidence review E1.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2021 Jun. (NICE Guideline, No. 198.)
Management options for moderate to severe acne – network meta-analyses: Acne vulgaris: management: Evidence review F1.
Secukinumab (Cosentyx): Therapeutic area: Hidradenitis suppurativa: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Jan.
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT.
Santer M, Lawrence M, Pyne S, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Sep. (Health Technology Assessment, No. 28.56.)
Acne vulgaris: management.
London: National Institute for Health and Care Excellence (NICE); 2023 Dec 7. (NICE Guideline, No. 198.)
InformedHealth.org [Internet].
Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.
Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults.
Geneva: World Health Organization; 2014.
Management options for mild to moderate acne – pairwise comparisons: Acne vulgaris: management: Evidence review E2.
Management options for moderate to severe acne – pairwise comparisons: Acne vulgaris: management: Evidence review F2.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on